Immunotoxicology of host-response-mediated experimental liver injury

Journal of Hepatology

Volumn 21, Issue 5, 1994, Pages 890-903

  Tiegs, Gisa ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CATECHOLAMINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; PENTOXIFYLLINE; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; EXPERIMENTAL LIVER CIRRHOSIS; HUMAN; IN VIVO STUDY; INFECTION; INFLAMMATION; LIVER FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS;

ANIMAL; AUTOIMMUNE DISEASES; CONCANAVALIN A; DISEASE MODELS, ANIMAL; GALACTOSAMINE; HUMAN; INFECTION; LIPOPOLYSACCHARIDES; LIVER DISEASES; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0027938118     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(94)80256-4     Document Type: Review

References (151)

1. Galactosamine-induced sensitization to the lethal effects of endotoxin
2. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice
3. A T cell-dependent experimental liver injury in mice inducible by concanavalin A
4. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
5. The pathogenesis of sepsis
6. Bacterial endotoxins: chemical structure, biological activity and role in septicaemia
7. Bacterial endotoxins
8. Leukotriene and hydroxyeicosatetraenoid acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs
9. Septic lung
10. Staphylococcal α-toxin-induced vascular leakage in isolated perfused rabbit lungs
11. Enterotoxins of Staphylococci
12. Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien
13. CD14 serves as the cellular receptor for complexes of lipopolysaccharide with lipopolysaccharide binding protien
14. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction
15. Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS binding protein and soluble CD14
16. Recognition of bacterial endotoxins by receptor-dependent mechanisms
17. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
18. The acute and chronic pathophysiologic effects of TNF: mediation of septic shock and wasting (cachexia)
19. Passive immunisation against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
20. Role of IL-1 in infection
21. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
22. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
23. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1)
24. Gamma interferon production in endotoxin-responder and -nonresponder mice during infection
25. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice
26. Acute antigen-induced elevation of serum colony stimulating factor (CSF) levels
27. GM-CSF enhances. G-CSF depressed endotoxin-induces TNF production and hepatitis in galactosamine-sensitized mice
28. Potentiation by granulocyte macrophage-colony stimulating factor (GM-CSF) of LPS toxicity in mice
29. Leukotriene antagonists prevent endotoxin lethality
30. Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action
31. Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo
32. Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo
33. 4 and PAF
34. Leukotrienes as mediators of ischemia and shock
35. Leukotriene-mediated liver injury
36. 2 and granulocyte elestase after severe trauma — relationship to complications and survival rates
37. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock
38. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone
39. Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice
40. Involvement of reactive oxygen species in endotoxin-induced hepatitis in galactosamine-sensitized mice
41. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
42. The L-arginine: nitric oxide pathway
43. Central role of macrophages in the host response to endotoxin
44. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin
45. Cytokines: coordinators of immune and inflammatory responses
46. Modulation of endothelial cell hemostatic properties by TNF: insights into the role of endothelium in the host response to inflammatory stimuli
47. Platelets
48. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor alpha increases neutrophil adherence by a CDw18-dependent mechanism
49. TNF modulation of endothelial and neutrophil adhesion
50. Adult respiratory distress syndrome
51. Endotoxin, reticuloendothelial function and liver injury
52. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells and murine inflammatory liver macrophages
53. TNF and the liver
54. A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days
55. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1
56. Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures
57. Interleukin 1 and the pathogenesis of acute-phase response
58. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression
59. Endotoxemia in liver disease
60. Clinical aspects of Kupffer cell failure in liver diseases
61. Clearance capacity of rat liver Kupffer, endothelial and parenchymal cells
62. Uptake of endotoxin by liver cells following its intravenous injection
63. Effect of bile acids on lipopolysaccharide uptake by cultured rat Kupffer cells
64. Mechanisms of endotoxemia in liver diseases: new experimental evidence
65. Pathology and pathophysiology of the liver
66. Hepatic microsomal drug metabolism after administration of endotoxin in rats
67. Oxygen-derived free radicals promote hepatic injury in the rat
68. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage
69. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum
70. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamme
71. The relation of leukotrienes to liver injury
72. Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis
73. A novel biologically active selenoorganic compound-VI: protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice
74. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice
75. T cell-mediated lethal shock triggered in mice by the superantigen staphyloccoccal enterotoxin B: critical role of tumor necrosis factor
76. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1
77. Leukocyte alterations do not account for hepatitis induces by endotoxin or TNFα in galactosamine-sensitized mice
78. Induction of manganous superoxide dismutase by tunor necrosis factor: possible protective mechanism
79. Murine hepatocyte apoptosis induced in vitro and in vivo by TNFα requires transcriptional arrest
80. Superantigens
81. Superantigens and their potential role in human disease
82. Superantigens in human diseases
83. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines
84. High affinity binding of staphylococcal enterotoxins A and B to HLA-DR
85. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice
86. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome
87. Induction of human interleukin-1 by toxic shock syndrome toxin-1
88. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma-interferon
89. Evidence for the effects of a superantigen in rheumatoid arthritis
90. Heat-shock proteins: immunity and autoimmunity
91. Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes
92. Sequence homologies between hsp60 and autoantigens
93. Heat shock proteins and immunity
94. Induced expression of heat shock protein (HSP) on bile ducts in patients with primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC)
95. Autoimmune disease and molecular mimicry: an hypothesis
96. Can enterobacterial antigens induce a primary biliary cirrhosis?
97. Membrane dihydroliponamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis
98. LKM-1 auto-antibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase
99. Septic shock: treatment
100. Lipopolysaccharide, die Endotoxine und O-Antigene gramnegativer Bakterien: Chemische Struktur, biologishce Wirkung und serologische Eigenschaften
101. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits
102. Biotech strategies for treatment of sepsis
103. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality
104. Cyclosporin A, FK 506, and rapamycin: pharmacological probes of lymphocyte signal transduction
105. The mechanism of action of cyclosporin A and FK 506
106. Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels
107. The effect of pentoxifylline in septic shock — new pharmacologic aspects of an established drug
108. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline
109. A novel xanthine derivative counteracting in vivo tumor necrosis factor α toxicity in mice
110. Inhibition of endogenous TNF formation by Pentoxifylline
111. Pentoxifylline suppresses OKT3-induced tumor necrosis factor alpha formation in renal transplant recipients
112. A neutrophil chemotactic factor derived from C'5 upon interaction of guinea pig serum with endotoxin
113. Oxygen-derived free radicals in postischemic tissue injury
114. Ischemic injury in the cat small intestine: role of superoxide radicals
115. Studies on the mechanism of galactosamine hepatitis accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase
116. Leukotrienes, oxygen radicals, and cytokines in septicemic mice
117. 2 analogue U-46619 in isolated perfused rat liver: metabolic, hemodynamic and iron-flux responses
118. Leukotrienes increase glucose and lactate output and decrease flow in perfused rat liver
119. The production of tumor necrosis factor α and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion
120. Role of tumor necrosis factor α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
121. Human leukocyte elastase and cathepsin G: structural and functional characteristics
122. Neutrophil-meidated injury to endothelial cells; enhancement by endotoxin and essential role of neutrophil elastase
123. The oxidative inactivation of human α-1-proteinase inhibitor; further evidence for methionine at the reactive center
124. Pathobiochemical mechanisms in inflammation
125. Involvement of tumor necrosis factor in LPS-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase
126. In vivo evidence for protease-catalyzed mechanism providing bioactive tumor necrosis factor α
127. Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-Toluene-sulfonyl-L-Arginine Methyl Ester (TAME)
128. Alpha-globulins suppress human leukocyte tumor necrosis factor secretion
129. Structural and physicochemical requirements of endotoxins for the activation of arachidonic acid metabolism in mouse peritoneal macrophages in vitro
130. The sensitized liver represents a rich source of endogenous leukotrienes
131. A link between extracellular reactive oxygen and endotoxin-induced release of tumor necrosis factor α in vivo
132. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury
133. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism
134. Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody
135. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor α
136. 4 synthesis
137. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation
138. Effects of recombinant human granulocyte and macrophage colony stimulating factors of signal transduction pathways in human granulocytes
139. Human GM-CSF and IL-3 stimulate monocyte cytotoxicity through a TNF-dependent mechanism
140. Drug therapy. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
141. Drug therapy of inflammation
142. Colchicine prevents tumor necrosis factor-induced toxicity in vivo
143. Possible requirement of internalisation in the mechanism of in vitro cytotoxicity of tumor necrosis serum
144. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells
145. The adhesion molecules of inflammation
146. Alterations in function, enzyme activities, and histopathology of the liver of the rat after administration of phytohemagglutinins (lectins)
147. Biological properties of lectins
148. Concanavalin A-induced T-cell mediated hepatic injury in mice: the role of tumor necrosis factor
149. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation